Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

RCUSRCUS
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in Arcus Biosciences, Inc.

GOLDMAN SACHS GROUP INC holds 1.4M shares of RCUS (Arcus Biosciences, Inc.), worth $42.8M as of 2026-Q2. The position was increased (+38.8% shares). RCUS represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$42.8M

Current Shares

1.4M

Total Value Change

+$36.2M

Total Shares Change

+944,113

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.4M
+38.8%
$42.8M0.0%$30.83
38
2026-Q1
Decreased
999,786
-14.4%
$21.6M0.0%$22.43
0
2025-Q4
Increased
1.2M
+22.9%
$27.8M0.0%$23.23
35
2025-Q3
Increased
950,589
+46.7%
$12.9M0.0%$13.32
38
2025-Q2
Decreased
648,074
-29.1%
$5.3M0.0%$7.95
0
2025-Q1
Increased
914,208
+106.2%
$7.2M0.0%$8.17
44
2024-Q4
New
443,453
-
$6.6M0.0%$14.91
38

Other major holders of RCUS: BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used